Vaccinex, Inc. Files 8-K Report
Ticker: VCNX · Form: 8-K · Filed: Aug 20, 2024 · CIK: 1205922
| Field | Detail |
|---|---|
| Company | Vaccinex, Inc. (VCNX) |
| Form Type | 8-K |
| Filed Date | Aug 20, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, 8-k
TL;DR
Vaccinex filed an 8-K on Aug 20, 2024. Standard corporate update.
AI Summary
On August 20, 2024, Vaccinex, Inc. filed an 8-K report. The filing indicates that the company is involved in the pharmaceutical preparations industry, specifically focusing on pharmaceutical preparations. The report details the company's principal executive offices located at 1895 Mount Hope Avenue, Rochester, New York, 14620.
Why It Matters
This filing provides an update on Vaccinex, Inc.'s corporate status and operational details, which is important for investors and stakeholders to monitor the company's official disclosures.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new financial or operational information that would immediately impact the company's risk profile.
Key Numbers
- 001-38624 — SEC File Number (Identifies the company's filing with the SEC)
- 161603202 — IRS Number (Company's Employer Identification Number)
Key Players & Entities
- VACCINEX, INC. (company) — Registrant
- August 20, 2024 (date) — Date of Report
- 1895 Mount Hope Avenue, Rochester, New York 14620 (location) — Principal executive offices
- 2834 (industry_code) — Standard Industrial Classification
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing serves as a current report for Vaccinex, Inc., detailing its corporate information and principal executive offices.
When was this 8-K report filed?
The 8-K report was filed on August 20, 2024.
What is Vaccinex, Inc.'s Standard Industrial Classification code?
Vaccinex, Inc.'s Standard Industrial Classification code is 2834, which pertains to Pharmaceutical Preparations.
Where are Vaccinex, Inc.'s principal executive offices located?
The principal executive offices of Vaccinex, Inc. are located at 1895 Mount Hope Avenue, Rochester, New York 14620.
What is the company's SEC File Number?
The company's SEC File Number is 001-38624.
Filing Stats: 541 words · 2 min read · ~2 pages · Grade level 13.1 · Accepted 2024-08-20 06:04:00
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share VCNX Nasdaq Capital Marke
Filing Documents
- d867905d8k.htm (8-K) — 23KB
- 0001193125-24-203149.txt ( ) — 138KB
- vcnx-20240820.xsd (EX-101.SCH) — 3KB
- vcnx-20240820_lab.xml (EX-101.LAB) — 17KB
- vcnx-20240820_pre.xml (EX-101.PRE) — 11KB
- d867905d8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Vaccinex, Inc. Date: August 20, 2024 By: /s/ Maurice Zauderer Maurice Zauderer Chief Executive Officer